You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 810 NX-1607, a small molecule inhibitor of CBL-B, enhances anti-PD-1-mediated tumor growth inhibition by reshaping intratumoral innate and adaptive immune response

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
810 NX-1607, a small molecule inhibitor of CBL-B, enhances anti-PD-1-mediated tumor growth inhibition by reshaping intratumoral innate and adaptive immune response

 

Online download statistics by month:

Online download statistics by month: November 2023 to November 2024

AbstractFullPdf
Nov 2023398043
Dec 2023126018
Jan 20243305
Feb 20244803
Mar 20243802
Apr 20244404
May 20242203
Jun 20242602
Jul 20243809
Aug 20243207
Sep 20244204
Oct 20243809
Nov 202452014
Total9370123